IP Library Granted Patent US 8,889,403
Granted Patent B2
US 8,889,403 · App. 13/394,471 · Granted Nov 18, 2014

Bioreactor for engineered tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,889,403
App. No.
13/394,471
Granted
Nov 18, 2014
Kind
B2
Abstract

A system for generating a tissue construct includes a mixing chamber, a piston chamber, a reaction chamber, and a pump. The mixing chamber is configured to receive a hydrogel solution and a cell suspension solution. The piston chamber includes a first piston and is configured to receive a mixture of the hydrogel solution and the cell suspension solution from the mixing chamber. The first piston is configured to push the mixture through one or more capillaries into the reaction chamber. The reaction is configured to receive the mixture and a cross-linking initiator. The pump is configured to move the mixture through the reaction chamber such that the mixture and the cross-linking initiator combine to form an encapsulated cell material.

Claims (14)

1. A system for generating a tissue construct comprising:

a bioreactor, the bioreactor comprising:

a mixing chamber configured to receive a hydrogel solution and a cell suspension solution;

a piston chamber including a first piston, wherein the piston chamber is configured to receive a mixture of the hydrogel solution and the cell suspension solution from the mixing chamber, and wherein the first piston is configured to push the mixture through one or more capillaries into a reaction chamber;

the reaction chamber configured to receive the mixture and a cross-linking initiator;

a membrane that separates the piston chamber from the reaction chamber, wherein the membrane only allows unidirectional flow from the piston chamber to the reaction chamber so that a new mixture can be introduced into the piston chamber after the mixture is pushed into the reaction chamber; and

a pump configured to move the mixture through the reaction chamber such that the mixture and the cross-linking initiator combine to form an encapsulated cell material.

2. The system of claim 1 , further comprising a compression chamber configured receive the encapsulated cell material from the reaction chamber, wherein the compression chamber includes a second piston configured to compress the encapsulated cell material into the tissue construct.

3. The system of claim 2 , further comprising a microscopy tool for use in determining when to release the tissue construct from the compression chamber.

4. The system of claim 1 , wherein the mixing chamber includes an impeller configured to form the mixture by mixing the hydrogel solution and the cell suspension solution.

5. The system of claim 1 , wherein the mixing chamber includes a valve that is configured to release air from the mixing chamber as one or more of the hydrogel solution and the cell suspension solution are introduced into the mixing chamber.

6. The system of claim 1 , wherein the first piston is drawn through the piston chamber to create a suction that pulls the mixture into the piston chamber from the mixing chamber.

7. The system of claim 6 , further comprising a valve that separates the mixing chamber from the piston chamber, wherein the valve is in an open position when the first piston is drawn through the piston chamber to introduce the mixture into the piston chamber.

8. The system of claim 7 , wherein the valve is in a closed position when the first piston pushes the mixture through the one or more capillaries into the reaction chamber.

Assignments (1)
SECURITY INTEREST Recorded Jan 29, 2019
From: EMPIRE TECHNOLOGY DEVELOPMENT LLC
To: CRESTLINE DIRECT FINANCE, L.P.
Reel/Frame 048373/0217 →